EAGLE - Multicenter Study of the European Assessment Group for Lysis in the Eye

NCT00637468 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

84

Enrollment

OTHER

Sponsor class

Stopped Due to results of conditional power analysis performed at the first interim analysis and due to observed spectrum of adverse events.

Conditions

Retinal Artery Occlusion
Fibrinolysis
Visual Acuity
Stroke
Hemodilution

Interventions

DRUG: Intravenous injection of heparin
DRUG: Intravenous injection of acetazolamide
PROCEDURE: Local intra-arterial fibrinolysis
PROCEDURE: Globe massage
DRUG: Topical use of beta-blocker
DRUG: Isovolaemic haemodilution
DRUG: Acetylsalicylic acid

Sponsor

University Hospital Freiburg

Collaborators

[object Object]